Report Summary

The global cell banking outsourcing market is estimated to grow at a CAGR of 26.6% between 2018 to 2025. Increasing preference for cell banking is observed as it is the most promising and emerging field in life sciences. Cell banking is a fully characterized, well documented, focusing on various critical attributes to migrate the risk related product safety for any biological products. In addition, companies offering cell banking services have to be aware that the services offered follows rules of CGMPs mentioned by the FDA. The increasing application of the Stem Cell due to increasing number of clinical trials has promoted the market of stem cell banking in the recent years. Human embryonic stem cells have great potential of regeneration and the recent approach for using stem cells in regenerative medicines has created impact on the entire industry growth.

The global cell banking outsourcing market growth is primarily driven by the rising number of clinical trials which has helped in unmasking the potential of stem cells and their relative applications. Similarly, rising awareness for stem cell banking in some of the developing countries, and increasing governments initiatives that promote awareness for stem cell isolation and related benefits are also factors expected to influence growth in this market during the forecast period. Increasing application of stem cells for developing personalized medicines to minimize the spread of various chronic diseases and also the association of aging with the inability of the body to maintain tissue turnover and hemostasis has helped researchers to focus on this target population for providing relative therapies that would act effectively on the damaged cells. Hence, this rising number of researches related to the application of stem cells is expected to support the market growth during forecast period. Furthermore, increase in the average life expectancy due to advanced medical research and improved general lifestyle of the population, and straightforward regulations for the stem cell researchers has created a greater market space. While, increasing adipose tissue banking has also become one of the major opportunities that has an inexpensively stored potential for its future use.

Segment Analysis

The global cell banking outsourcing market is segmented on the basis of type, product, cell type, phase, and geography. On the basis of type of cell banking, the global cell banking outsourcing market is sub-segmented into master cell banking, viral cell banking, and working cell banking. Master cell banking segment is observed to hold the largest market share.

Based on product type, the global cell banking outsourcing market covers cord cell banking, adult stem cell banking, IPS stem cell banking, and embryonic stem cell banking. Cord cell banking accounts for the largest market share owing to the rising number of cord blood banks and cord blood banking services across the globe. Additionally, increasing number of genetic diseases that can be effectively treated by the isolated cord cells is expected to have a positive influence on the segment growth during forecast period. However, high cost incurred for isolation of cord cell and stringent government policies might hinder the market growth.

On the basis of cell type, the global cell banking outsourcing market is sub-segmented into stem cell and non-stem cell type. Stem cell segment to hold the major market share owing to factors such as increasing availability of stem cells from different organs and relative flexible use of these cells.

Based on phase, the global cell banking outsourcing market is sub-segmented into bank storage, bank preparation, and bank characterization & testing. Bank storage segment is projected to hold significant market share owing to factors such as need for proper storage of the cells and proper maintenance prerequisite. Moreover, technological advancements in cryopreservation technologies to preserve these isolated cells are also expected to drive the growth in this market. Presence of increasing research for developing cell lines are expected to generate lucrative market opportunities during the upcoming years.

Cell Banking Outsourcing Market Scope

By Type By Product Type By Cell Type By Phase Type By Region Master Cell Banking

Viral Cell Banking

Working Cell Banking Cord Cell Banking

Adult Stem Cell Banking

IPS Stem Cell Banking

Embryonic Stem Cells Stem Cell

Non-stem Cell Bank Storage

Working Cell Bank Storage

Master Cell Bank Storage

Cell Storage Stability Testing

Bank Preparation

Bank Characterization & Testing North America (U.S., Canada)

Europe (Germany, UK, France, Italy, Spain, Belgium, Russia, Netherlands)

Asia-Pacific (China, Japan, India, Australia, Korea, Singapore, Malaysia, Indonesia, Thailand, Philippines)

Latin America (Brazil, Mexico, Argentina)

Middle East and Africa (UAE, Saudi Arabia, South Africa)

Know more about this report: request for sample pages

Regional Analysis

By geography, the global cell banking outsourcing market covers five major regions, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America cell bank outsourcing market to dominate this market in terms of revenue and market share during 2017. The growth of North American market is majorly driven due to increasing number biopharmaceutical companies and manufacturers in this region, and increasing awareness for the use of stem cells as therapeutics proteins and antibiotics. Moreover, presence of regulatory authorities that promotes continuous R&D activities, and increasing number of registrations by International Conference on Harmonization to also drive the market growth in North America. While, Asia Pacific is observed to be the fastest growing market during the forecast period. Growth in this region is attributed to the increase in life science sectors along with the help of supportive government initiatives pertaining to investment on biotechnology sector.

Competitive Analysis

Some of the major key players operating in global Cell banking outsourcing market includes BioReliance, Covance, GlobalStem Inc., BSL Bioservice, Cleancells, Charles River Laboratories Lonza, Toxikon Corporation, Cryobanks International India, Wuxi Apptec, Reliance Life Sciences, LifeCell International Pvt. Ltd., BioOutsource (Sartorious), CordLife, PX’Therapeutics SA, SGS Life Sciences, Texcell, and Cryo-Cell International Inc.